Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson's disease (PD). To explore the utility of plasma α-synuclein in the prodromal phase of PD, plasma total and NDE α-synuclein were evaluated in baseline and 2-year follow-u...
Main Authors: | Hua Wang, Anzari Atik, Tessandra Stewart, Carmen Ginghina, Patrick Aro, Kathleen F. Kerr, John Seibyl, Danna Jennings, Poul Henning Jensen, Kenneth Marek, Min Shi, Jing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996118301232 |
Similar Items
-
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
by: Chen Tian, et al.
Published: (2019-05-01) -
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
by: Haichen Niu, et al.
Published: (2018-09-01) -
Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease
by: Stewart F. Graham, et al.
Published: (2018-10-01) -
Animal Model for Prodromal Parkinson’s Disease
by: Tomoyuki Taguchi, et al.
Published: (2020-03-01) -
Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
by: Na Li, et al.
Published: (2020-09-01)